Barbara Scappini
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 45
- Acute Myeloid Leukemia Research 23
- Chronic Myeloid Leukemia Treatments 23
- Multiple Myeloma Research and Treatments 5
- Hematopoietic Stem Cell Transplantation 4
- Genetics 21
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 9
- Co-authors
- Hagop Kantarjian (7 shared papers)Francesco Onida (7 shared papers)Srđan Verstovšek (6 shared papers)Miloslav Beran (3 shared papers)Michael J. Keating (4 shared papers)Antonella Gozzini (13 shared papers)Vladimír Divoký (3 shared papers)Clara Ricci (3 shared papers)
- Journals
- Blood (10 papers)Haematologica (6 papers)Hematological Oncology (3 papers)Cancers (3 papers)HemaSphere (3 papers)
- Partner nations
- ItalyUnited StatesCzechia
In The Last Decade
Barbara Scappini
57 papers receiving 904 citations
Peers
Comparison fields: 5 of 76
- Hematology 618
- Genetics 313
- Rheumatology 129
- Oncology 133
- Immunology 86
Countries citing papers authored by Barbara Scappini
This map shows the geographic impact of Barbara Scappini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Scappini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Scappini more than expected).
Fields of papers citing papers by Barbara Scappini
This network shows the impact of papers produced by Barbara Scappini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Scappini. The network helps show where Barbara Scappini may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Scappini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 76 | |
| 2 | Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line. | 2002 | 69 |
| 3 | The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate. | 2003 | 64 |
| 4 | 2016 | 59 | |
| 5 | 2002 | 50 | |
| 6 | 2020 | 49 | |
| 7 | 2011 | 35 | |
| 8 | 2004 | 35 | |
| 9 | 2016 | 32 | |
| 10 | 2021 | 28 | |
| 11 | 2001 | 26 | |
| 12 | 2012 | 25 | |
| 13 | 2016 | 24 | |
| 14 | 2019 | 23 | |
| 15 | 1999 | 22 | |
| 16 | 2014 | 20 | |
| 17 | 2003 | 20 | |
| 18 | 2005 | 18 | |
| 19 | 2011 | 17 | |
| 20 | Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells. | 2001 | 16 |
About Barbara Scappini
Barbara Scappini is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Immunology and Oncology, having authored 63 papers that have together received 921 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (23 papers), Chronic Myeloid Leukemia Treatments (23 papers), Acute Lymphoblastic Leukemia research (10 papers), Chronic Lymphocytic Leukemia Research (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Histone Deacetylase Inhibitors Research (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Hematopoietic Stem Cell Transplantation (4 papers). The work is most often cited by research in Hematology (618 citations), Genetics (313 citations), Rheumatology (129 citations), Oncology (133 citations) and Immunology (86 citations). Barbara Scappini has collaborated with scholars based in Italy, United States and Czechia. Frequent co-authors include Hagop Kantarjian, Francesco Onida, Srđan Verstovšek, Miloslav Beran, Michael J. Keating, Antonella Gozzini, Vladimír Divoký, Clara Ricci, Alberto Bosi and Greg Ball. Their work appears in journals such as Blood, Haematologica, Hematological Oncology, Cancers and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.